ArticleExperimental and therapeutic medicine2019

miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.

Changpo Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.